AI assistance raised detection rates of actionable lung nodules on LDCT but did not reduce interpretation time for radiologists.
Key Details
- 1911 asymptomatic adults received LDCT exams, randomized to AI-assisted (n=447) or standard (n=464) interpretation.
- 2Commercial AI tool (Aview Lung Nodule CAD, Coreline Soft) used for nodule identification, classification, and measurement.
- 3AI group detected significantly more Lung-RADS-positive nodules (16.9% vs. 10.3%, p=0.03) and all nodules (52.9% vs. 32.6%, p=0.002).
- 4Interpretation time was not reduced with AI (187s with AI vs. 172s without AI, p=0.23).
- 5AI group had higher frequency of follow-up LDCT recommendations (15.3% vs. 7.4%, p=0.04).
- 6No individual in either group developed lung cancer during median follow-up.
Why It Matters
While AI integration increased detection of clinically relevant findings, it did not improve workflow efficiency and increased follow-up imaging, raising questions about the real-world value and resource implications of AI in lung screening protocols.
Source
AuntMinnie
Related News
•Radiology Business
Aidoc Raises $150M to Expand Imaging AI Portfolio and Global Reach
Aidoc secures $150M in Series E funding led by Goldman Sachs to accelerate expansion of its clinical AI platform.
•AuntMinnie
Radiology and AI Poised to Transform Endometriosis Diagnosis
Advances in imaging and AI are improving early detection and management of endometriosis.
•Radiology Business
AI Model Outperforms Radiologists in Early Pancreatic Cancer Detection
REMOD, a new AI model, detects pancreatic cancer on CT scans much earlier and more accurately than radiologists.